Back to results
US 2014/0271868 A1Published application
Treatment of achondroplasia with encapsulated cnp-secreting cells
AssigneeHepacore Ltd.
InventorsMyriam Golembo, Avner Yayon
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for the treatment of skeletal dysplasia by administering to a patient a composition comprising a therapeutically effective amount of at least one C-type natriuretic peptide (CNP).
Claims13
A method for the treatment of skeletal dysplasia which comprises administering to a patient a composition comprising natriuretic peptide secreting cells.
Dependencies are inferred from the claim text.